I henhold til CHMPs guidelines om Risk Management- systemer for lægemidler til human brug, skal en opdateret RMP indsendes samtidig som den næste Periodic Safety Update Report (PSUR).
As per the CHMP Guideline on Risk Management Systems for medicinal products for human use, the updated RMP should be submitted at the same time as the next Periodic Safety Update Report (PSUR).